Thrombospondin-1 in differentiated thyroid cancer: Dr. Jekyll and Mr. Hyde

Connective Tissue Research

Volumn 49, Issue 3-4, 2008, Pages 257-260

  Ghoneim, Christelle ^a   Soula Rothhut, Mahdhia ^a   Rothhut, Bernard ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

Angiogenesis; Extracellular matrix; Peptide growth factor; Receptor tyrosine kinase; Thrombospondin 1; Thyroid carcinoma; Tumor progression

Indexed keywords

CELL SURFACE RECEPTOR; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCOPROTEIN; GROWTH FACTOR RECEPTOR; MATRIX PROTEIN; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; SCLEROPROTEIN; THROMBOSPONDIN 1;

ANGIOGENESIS; CANCER CLASSIFICATION; CANCER GROWTH; CARCINOGENESIS; CELL INTERACTION; CELL INVASION; EXTRACELLULAR MATRIX; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN FAMILY; REGULATORY MECHANISM; REVIEW; THYROID CARCINOMA;

CARCINOMA, PAPILLARY; CARCINOMA, PAPILLARY, FOLLICULAR; DOWN-REGULATION; EPIDERMAL GROWTH FACTOR; EXTRACELLULAR MATRIX; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; THROMBOSPONDIN 1; THYROID NEOPLASMS; UP-REGULATION;

EID: 48549099669     PISSN: 03008207     EISSN: 16078438     Source Type: Journal    
DOI: 10.1080/03008200802147795     Document Type: Review

References (29)

1. Robbins, J., Merino, M. J., Boice, Jr., Ron, E., Ain, K. B., Alexander, H. R., Norton, J. A. and Reynolds, J. (1991) Thyroid cancer: A lethal endocrine neoplasm. 115, pp. 133-147.
2. Woolner, L. B., Beahrs, O. H., Black, B. M., Mc, C. W. and Keating, Jr. (1961) Classification and prognosis of thyroid carcinoma. A study of 885 cases observed in a thirty year period. 102, pp. 354-387.
3. DeGroot, L. J., Kaplan, E. L., Shukla, M. S., Salti, G. and Straus, F. H. (1995) Morbidity and mortality in follicular thyroid cancer. 80, pp. 2946-2953.
4. Caron, N. R. and Clark, O. H. (2005) Papillary thyroid cancer: Surgical management of lymph node metastases. 6, pp. 311-322.
5. Bergholm, U., Adami, H. O., Bergstrom, R., Johansson, H., Lundell, G., Telenius-Berg, M. and Akerstrom, G. (1989) Clinical characteristics in sporadic and familial medullary thyroid carcinoma. A nationwide study of 249 patients in Sweden from 1959 through 1981. 63, pp. 1196-1204.
6. Nel, C. J., van Heerden, J. A., Goellner, J. R., Gharib, H., McConahey, W. M., Taylor, W. F. and Grant, C. S. (1985) Anaplastic carcinoma of the thyroid: A clinicopathologic study of 82 cases. 60, pp. 51-58.
7. Kebebew, E., Greenspan, F. S., Clark, O. H., Woeber, K. A. and McMillan, A. (2005) Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. 103, pp. 1330-1335.
8. McIver, B., Hay, I. D., Giuffrida, D. F., Dvorak, C. E., Grant, C. S., Thompson, G. B., van Heerden, J. A. and Goellner, J. R. (2001) Anaplastic thyroid carcinoma: A 50-year experience at a single institution. 130, pp. 1028-1034.
9. Bornstein, P. (1995) Diversity of function is inherent in matricellular proteins: An appraisal of thrombospondin 1. 130, pp. 503-506.
10. Baenziger, N. L., Brodie, G. N. and Majerus, P. W. (1971) A thrombin-sensitive protein of human platelet membranes. 68, pp. 240-243.
11. Mosher, D. F., Doyle, M. J. and Jaffe, E. A. (1982) Synthesis and secretion of thrombospondin by cultured human endothelial cells. 93, pp. 343-348.
12. Jaffe, E. A., Ruggiero, J. T., Leung, L. K., Doyle, M. J., McKeown-Longo, P. J. and Mosher, D. F. (1983) Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix. 80, pp. 998-1002.
13. Raugi, G. J., Mumby, S. M., Abbott-Brown, D. and Bornstein, P. (1982) Thrombospondin: Synthesis and secretion by cells in culture. 95, pp. 351-354.
14. Bornstein, P. and Sage, E. H. (1994) Thrombospondins. 245, pp. 62-85.
15. Roberts, D. D. (1996) Regulation of tumor growth and metastasis by thrombospondin-1. 10, pp. 1183-1191.
16. Adams, J. C. (2001) Thrombospondins: Multifunctional regulators of cell interactions. 17, pp. 25-51.
17. Sargiannidou, I., Zhou, J. and Tuszynski, G. P. (2001) The role of thrombospondin-1 in tumor progression. 226, pp. 726-733.
18. Good, D. J., Polverini, P. J., Rastinejad, F., Le Beau, M.M., Lemons, R. S., Frazier, W. A. and Bouck, N. P. (1990) A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. 87, pp. 6624-6628.
19. Iruela-Arispe, M. L., Bornstein, P. and Sage, H. (1991) Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. 88, pp. 5026-5030.
20. Tuszynski, G. P., Gasic, T. B., Rothman, V. L., Knudsen, K. A. and Gasic, G. J. (1987) Thrombospondin, a potentiator of tumor cell metastasis. 47, pp. 4130-4133.
21. Castle, V. P., Dixit, V. M. and Polverini, P. J. (1997) Thrombospondin-1 suppresses tumorigenesis and angiogenesis in serum- and anchorage-independent NIH 3T3 cells. 77, pp. 51-61.
22. Bunone, G., Vigneri, P., Mariani, L., Buto, S., Collini, P., Pilotti, S., Pierotti, M. A. and Bongarzone, I. (1999) Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. 155, pp. 1967-1976.
23. Scarpino, S., Di Napoli, A., Taraboletti, G., Cancrini, A. and Ruco, L. P. (2005) Hepatocyte growth factor (HGF) downregulates thrombospondin 1 (TSP-1) expression in thyroid papillary carcinoma cells. 205, pp. 50-56.
24. Patey, M., Delemer, B., Bellon, G., Martiny, L., Pluot, M. and Haye, B. (1999) Immunohistochemical study of thrombospondin and its receptors alpha root of beta 3 and CD36 in normal thyroid and in thyroid tumours. 52, pp. 895-900.
25. Tanaka, K., Sonoo, H., Kurebayashi, J., Nomura, T., Ohkubo, S., Yamamoto, Y. and Yamamoto, S. (2002) Inhibition of infiltration and angiogenesis by thrombospondin-1 in papillary thyroid carcinoma. 8, pp. 1125-1131.
26. Kim, D. S., Franklyn, J. A., Stratford, A. L., Boelaert, K., Watkinson, J. C., Eggo, M. C. and McCabe, C. J. (2006) Pituitary tumor-transforming gene regulates multiple downstream angiogenic genes in thyroid cancer. 91, pp. 1119-1128.
27. Soula-Rothhut, M., Coissard, C., Sartelet, H., Boudot, C., Bellon, G., Martiny, L. and Rothhut, B. (2005) The tumor suppressor PTEN inhibits EGF-induced TSP-1 and TIMP-1 expression in FTC-133 thyroid carcinoma cells. 304, pp. 187-201.
28. Ghoneim, C., Soula-Rothhut, M., Blanchevoye, C., Martiny, L., Antonicelli, F. and Rothhut, B. (2007) Activating transcription factor-1-mediated hepatocyte growth factor-induced down-regulation of thrombospondin-1 expression leads to thyroid cancer cell invasion. 282, pp. 15490-15497.
29. Rath, G. M., Schneider, C., Dedieu, S., Rothhut, B., Soula-Rothhut, M., Ghoneim, C., Sid, B., Morjani, H., El Btaouri, H. and Martiny, L. (2006) The C-terminal CD47/IAP-binding domain of thrombospondin-1 prevents camptothecin- and doxorubicin-induced apoptosis in human thyroid carcinoma cells. 1763, pp. 1125-1134.